View of SARS-CoV-2 vaccinations reduce the prevalence of post-COVID Guillain-Barre syndrome

Return to Article Details SARS-CoV-2 vaccinations reduce the prevalence of post-COVID Guillain-Barre syndrome Download Download PDF